Gene expression in hippocampus as a function of differential trait anxiety levels in genetically heterogeneous NIH-HS rats

Behavioural Brain Research

Volumn 257, Issue , 2013, Pages 129-139

  Díaz Morán, Sira ^a   Palència, Marta ^a   Mont Cardona, Carme ^a,b   Cañete, Toni ^a   Blázquez, Gloria ^a   Martínez Membrives, Esther ^a   López Aumatell, Regina ^b   Sabariego, Marta ^c   Donaire, Rocío ^c   Morón, Ignacio ^d   Torres, Carmen ^c   Martínez Conejero, José Antonio ^e   Tobeña, Adolf ^a   Esteban, Francisco José ^c   Fernández Teruel, Alberto ^a  

^a INSTITUT DE NEUROCIÈNCIES   (Spain)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF JAÉN   (Spain)

^d UNIVERSITY OF GRANADA   (Spain)

^e IGenomix   (Spain)

Author keywords

Anxiety; Fear; Gene expression; Genetically heterogeneous rats; Hippocampus

Indexed keywords

CD74 ANTIGEN;

ACCN3 GENE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; AVOIDANCE BEHAVIOR; AVPR1B GENE; BRAIN TISSUE; CD74 GENE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DOWN REGULATION; FEAR; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC RECOMBINATION; HIPPOCAMPUS; INFLAMMATION; LTB GENE; MALE; MAZE TEST; MICROARRAY ANALYSIS; NATIONAL INSTITUTES OF HEALTH GENETICALLY HETEROGENEOUS RAT; NEUROENDOCRINOLOGY; NEUROIMMUNOLOGY; NONHUMAN; NRG2 GENE; NUCLEOTIDE SEQUENCE; OPRDL1 GENE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS MAPPING; RAT; RAT STRAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RT1 EC12 GENE; SLC10A4 GENE; SLC5A7 GENE; STRESS; UPREGULATION;

ANXIETY; FEAR; GENE EXPRESSION; GENETICALLY HETEROGENEOUS RATS; HIPPOCAMPUS;

ACID SENSING ION CHANNELS; ANIMALS; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; ANXIETY; AVOIDANCE LEARNING; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; GENE EXPRESSION REGULATION; GENETIC HETEROGENEITY; HIPPOCAMPUS; HISTOCOMPATIBILITY ANTIGENS; HISTOCOMPATIBILITY ANTIGENS CLASS II; LYMPHOTOXIN-BETA; MALE; MAZE LEARNING; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; ORGANIC ANION TRANSPORTERS, SODIUM-DEPENDENT; PLASMA MEMBRANE NEUROTRANSMITTER TRANSPORT PROTEINS; RATS; RECEPTORS, VASOPRESSIN; SYMPORTERS;

EID: 84886078163     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.09.041     Document Type: Article

References (86)

1. Gray J. The neuropsychology of anxiety 1982, Oxford University Press, New York.
2. Gray J., McNaughton N. The neuropsychology of anxiety 2000, Oxford University Press, New York.
3. McNaughton N. Cognitive dysfunction resulting from hippocampal hyperactivity - a possible cause of anxiety disorder?. Pharmacol Biochem Behav 1997, 56:603-611.
4. Escorihuela R.M., Fernández-Teruel A., Zapata A., Núñez J.F., Tobeña A. Flumazenil prevents the anxiolytic effects diazepam, alprazolam and adinazolam on the early acquisition of two-way active avoidance. Pharmacol Res 1993, 28:53-58.
5. Fernández-Teruel A., Escorihuela R.M., Núñez J.F., Zapata A., Boix F., Salazar W., et al. The early acquisition of two-way (shuttle-box) avoidance as an anxiety-mediated behavior: psychopharmacological validation. Brain Res Bull 1991, 26:173-176.
6. Garcia-Falgueras A., Castillo-Ruiz M.M., Put T., Tobeña A., Fernández-Teruel A. Differential hippocampal neuron density between inbred Roman high- (low anxious) and low-avoidance (high anxious) rats. Neurosci Lett 2012, 522:41-46.
7. Driscoll P., Bättig K. Behavioral, emotional and neurochemical profiles of rats selected of extreme differences in active, two-way avoidance performance. Genetics of the brain. 1982, 95-123. Elsevier Biomedical Press, Amsterdam. I. Liebrich (Ed.).
8. Lipp H.P., Schwegler H., Crusio W.E., Wolfer D.P., Leisinger-Trigona M.C., Heimrich B., et al. Using genetically-defined rodent strains for the identification of hippocampal traits relevant for two-way avoidance behavior: a non-invasive approach. Experientia 1989, 45:845-859.
9. Sallés J., López de Jesús M., Goñi O., Fernández-Teruel A., Driscoll P., Tobeña A., et al. Transmembrane signaling through phospholipase C in cortical and hippocampal membranes of psychogenetically selected rat lines. Psychopharmacology (Berl) 2001, 154:115-125.
10. Meiza K.Z., Boguszewski P.M., Nikolaev E., Zagrodzka J. Diverse sensitivity of RHA/Verh and RLA/Verh rats to emotional and spatial aspects of a novel environment as a result of disctinct pattern of neuronal activation in the fear/anxiety circuit. Behav Genet 2009, 39:48-61.
11. Brown E.S.J., Woolston D., Frol A., Bobadilla L., Khan D.A., Hanczyc M., et al. Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy. Biol Psychiatry 2004, 55:538-545.
12. D'Agata V., Cavallaro S. Hippocampal gene expression profiles in passive avoidance conditioning. Eur J Neurosci 2003, 18:2835-2841.
13. Díaz-Morán S., Palència M., Mont-Cardona C., Cañete T., Blázquez G., Martínez-Membrives E., et al. Gene expression in amygdala as a function of differential trait anxiety levels in genetically heterogeneous NIH-HS rats. Behav Brain Res 2013, 252:422-431.
14. González-Perez O., Ramos-Remus C., Garcia-Estrada J., Luquin S. Prednisone induces anxiety and glial cerebral changes in rats. J Rheumatol 2001, 28:2529-2534.
15. Kajiyama Y., Iijima Y., Chiba S., Furuta M., Ninomiya M., Izumi A., et al. Prednisolone causes anxiety- and depression-like behaviors and altered expression of apoptotic genes in mice hippocampus. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34:159-165.
16. Mei B., Li C., Dong S., Jiang C.H., Wang H., Hu Y. Distinct gene expression profiles in hippocampus and amygdala after fear conditioning. Brain Res Bull 2005, 67:1-12.
17. Zhang S., Amstein T., Shen J., Brush R.F., Gershenfeld H.K. Molecular correlates of emotional learning using genetically selected rat lines. Genes Brain Behav 2005, 4:99-109.
18. Hansen C., Spuhler K. Development of the National Institutes of Health genetically heterogeneous stock. Alcohol Clin Exp Res 1984, 8:477-479.
19. López-Aumatell R., Guitart-Masip M., Vicens-Costa E., Giménez-Llort L., Valdar W., Johannesson M., et al. Fearfulness in a large N/Nih genetically heterogeneous rat stock: differential profiles of timidity and defensive flight in males and females. Behav Brain Res 2008, 188:41-55.
20. Johannesson M., López-Aumatell R., Stridh P., Díez M., Tuncel J., Blázquez G., et al. A resource for the simultaneous high-resolution mapping of multiple quantitative trait loci in rats: the NIH heterogeneous stock. Genome Res 2009, 19:150-158.
21. Díaz-Morán S., Palencia M., Mont C., Cañete T., Blázquez G., Martínez-Membrives E., et al. Coping style and stress hormone responses in genetically heterogeneous rats: comparison with the Roman rat strains. Behav Brain Res 2012, 228:203-210.
22. López-Aumatell R., Vicens-Costa E., Guitart-Masip M., Martínez-Membrives E., Valdar W., Johannesson M., et al. Unlearned anxiety predicts learned fear: a comparison among heterogeneous rats and the Roman rat strains. Behav Brain Res 2009, 202:92-101.
23. López-Aumatell R., Martínez-Membrives E., Vicens-Costa E., Cañete T., Blázquez G., Mont-Cardona C., et al. Effects of environmental and physiological covariates on sex differences in unconditioned and conditioned anxiety and fear in a large sample of genetically heterogeneous (N/Nih-HS) rats. Behav Brain Funct 2011, 7:48.
24. Vicens-Costa E., Martínez-Membrives E., López-Aumatell R., Guitart-Masip M., Cañete T., Blázquez G., et al. Two-way avoidance acquisition is negatively related to conditioned freezing and positively associated with startle reactions: a dissection of anxiety and fear in genetically heterogeneous rats. Physiol Behav 2011, 103:148-156.
25. Baud A., Calderari S., Mott R., Flint J., Gauguier D. Genome sequencing and genetic mapping to dissect the genetic basis of complex traits. Med Sci 2013, 29:671-674.
26. Alam S.M., Ain R., Konno T., Ho-Chen J.K., Soares M.J. The rat prolactin gene family locus: species-specific gene family expansion. Mamm Genome 2006, 17:858-877.
27. Solberg L.C., Holl K., Tschannen M., Valdar W. Fine-mapping a locus for glucose tolerance using heterogeneous stock rats. Physiol Genomics 2010, 41:102-108.
28. Shepherd J.K., Grewal S.S., Fletcher A., Bill D.J., Dourishmm C.T. Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety. Psychopharmacology (Berl) 1994, 116:56-64.
29. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1997, Academic Press, Sydney. 4th ed.
30. Schroeder A., Mueller O., Stocker S., Salowsky R., Leiber M., Gassmann M., et al. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 2006, 31. 7-3.
31. Kabbaj M. Neurobiological bases of individual differences in emotional and stress responsiveness. High responders-Low responders model. Arch Neurol 2004, 61:1009-1010.
32. Zhang M., Gong N., Lu Y.G., Jia N.L., Xu T.L., Chen L. Functional characterization of acid-sensing ion channels in cultured neurons of rat inferior colliculus. Neuroscience 2008, 154:461-472.
33. Wang H., Zhu Y.Z., Wong P.T.H., Farook J.M., Teo A.L., Lee L.K.H., et al. cDNA microarray analysis of gene expression in anxious PVG and SD rats after cat-freezing test. Exp Brain Res 2003, 149:413-421.
34. Sabariego M., Gómez M.J., Morón I., Torres C., Fernández-Teruel A., Tobeña A., et al. Differential gene expression between inbred Roman high- (RHA-I) and low- (RLA-I) avoidance rats. Neurosci Lett 2011, 504:265-270.
35. Wu S., Hsu L.A., Chou H.H., Teng M.S., Chang H.H., Yeh K.H., et al. Association between an ASIC3 gene variant and insulin resistance in Taiwanese. Clin Chim Acta 2010, 411:1132-1136.
36. Meng Q.Y., Wang W., Chen X.N., Xu T.L., Zhou J.N. Distribution of acid-sensing ion channel 3 in the rat hypothalamus. Neuroscience 2009, 159:1126-1134.
37. Chen C.H., Hsu Y.T., Chen C.C., Huang R.C. Acidsensing ion channels in neurones of the rat suprachiasmatic nucleus. J Physiol 2009, 587:1727-1737.
38. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4:44.
39. Huang da W., Sherman B.T., Lempicki R.A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009, 37:1.
40. Sluka K.A., Price M.P., Breese N.M., Stucky C.L., Wemmie J.A., Welsh M.J. Chronic hyperalgesia induced by repeated acid injections in muscle is abolished by the loss of ASIC3, but not ASIC1. Pain 2003, 106:229-239.
41. Lin C.C., Chen W.N., Chen C.J., Lin Y.W., Zimmer A., Chen C.C. An antinociceptive role for substance P in acid-induced chronic muscle pain. Proc Natl Acad Sci USA 2012, 109:E76-E83.
42. Yiangou Y., Facer P., Smith J.A., Sangameswaran L., Eglen R., Birch R., et al. Increased acid-sensing ion channel ASIC-3 in inflamed human intestine. Eur J Gastroenterol Hepatol 2001, 13:891-896.
43. Huang S.J., Yang W.S., Lin Y.W., Wang H.C., Chen C.C. Increase of insulin sensitivity and reversal of age-dependent glucose intolerance with inhibition of ASIC3. Biochem Biophys Res Commun 2008, 371:729-734.
44. Wu W., Cheng C., Sun W., Wong C., Chen C. Targeting ASIC3 for pain, anxiety, and insulin resistance. Pharmacol Therapeut 2012, 134:127-138.
45. Vralsted V.C., Price M.P., Du J., Schnizler M., Wunsch A.M., Ziemann A.E., et al. Expressing acid-sensing ion channel 3 in the brain alters acid-evoked currents and impairs fear conditioning. Genes Brain Behav 2011, 10:444-450.
46. Gavioli E.C., Rizzi A., Marzola G., Zucchini S., Regoli D., Calo G. Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice. Peptides 2007, 28:1229-1239.
47. Boom A., Mollereau C., Meunier J.C., Vassart G., Parmentier M., Vanderhaeghen J.J., et al. Distribution of the nociceptin and nocistatin precursor transcript in the mouse central nervous system. Neurosciences 1999, 91:991-1007.
48. Le Maitre E., Vilpoux C., Costentin J., Leroux-Nicollet I. Opioid receptor-lie 1 (NOP) receptors in the rat dorsal raphe nucleus: evidence for localization on serotoninergic neurons and functional adaptation after 5,7-dihydroxytryptamine lesion. J Neurosci Res 2005, 81:488-496.
49. Marti M., Mela F., Veronesi C., Guerrini R., Salvadori S., Federici M., et al. Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior. J Neurosci 2004, 24:6659-6666.
50. Duzzioni M., Duarte F.S., Leme L.R., Gavioli E.C., De Lima T.C. Anxiolytic-like effect of central administration of NOP receptor antagonist UFP-101 in rats submitted to the elevated T-maze. Behav Brain Res 2011, 222:206-211.
51. Aujla H., Cannarsa R., Romualdi P., Ciccocioppo R., Martin-Fardon R., Weiss F. Modification of anxiety-like behaviors by nociceptin/orphanin FQ (N/OFQ) and time-dependent changes in N/OFQ-NOP gene expression following ethanol withdrawal. Addict Biol 2013, 18:467-479.
52. Nativio P., Pascale E., Maffei A., Scaccianoce S., Passarelli F. Effect of stress on hippocampal nociceptin expression in the rat. Stress 2012, 15:378-384.
53. Andero R., Brothers S.P., Jovanovic T., Chen Y.T., Salah-Uddin H., Cameron M., et al. Amygdala-dependent fear is regulated by Oprl1 in mice and humans with PTSD. Sci Transl Med 2013, 5:188ra73.
54. Leong L.Y.W., Le Rolle A., Deverson E.V., Powis S.J., Larkins A.P., Vaage J.T., et al. TR1-U: identification of a novel, active, class Ib alloantigen of the rat MHC. J Immunol 1999, 162:743-752.
55. Hurt P., Walter L., Sudbrak R., Klages S., Müller I., Shiina T., et al. The genomic sequence and comparative analysis of the rat major histocompatibility complex. Genome Res 2004, 14:631-639.
56. Shatz C.J. MHC class I: an unexpected role in neuronal plasticity. Neuron 2009, 64:40-45.
57. Frank M.G., Baratta M.V., Sprunger D.V., Watkins L.R., Maier S.F. Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses. Brain Behav Immun 2007, 21:47-59.
58. Huh G.S., Boulanger L.M., Du H., Riquelme P.A., Brotz T.M., Shatz C.J. Functional requirement for class I MHC in CNS development and plasticity. Science 2000, 290:2155-2159.
59. Liu J., Shen Y., Li M., Shi Q., Zhang A., Miao F., et al. The expression pattern of classical MHC class I molecules in the development of mouse central nervous system. Neurochem Res 2013, 38:290-299.
60. Borghese F., Clanchy F.I. CD74: an emerging opportunity as a therapeutic target in cancer and autoimmune disease. Expert Opin Ther Targets 2011, 15:237-251.
61. Faure-André G., Vargas P., Yuseff M.I., Heuzé M., Diaz J., Lankar D., et al. Regulation of dendritic cell migration by CD74, the MHC class II-associated invariant chain. Science 2008, 322:1705-1710.
62. Sacca R., Cuff C.A., Lesslauer W., Ruddle N.H. Differential activities of secreted lymphotoxin-a3 and membrane lymphotoxin-a1b2 in lymphotoxin-induced inflammation: critical role of TNF receptor 1 signaling. J Immunol 1997, 160:485-491.
63. Lee C.M., Knight B., Yeoh G., Ramm G., Olynyk J.K. Lymphotoxin-β production following bile duct ligation: possible role for Kupffer cells. J Gastroenterol Hepatol 2005, 20:1762-1768.
64. Mi W., Prentice T.W., Young C.R., Johnson R.R., Sieve A.N., Meagher M.W., et al. Restraint stress decreases virus-induced pro-inflammatory cytokine mRNA expression during acute Theiler's virus infection. J Neuroimmunol 2006, 178:49-61.
65. Engin E., Treit D. Dissociation of the anxiolytic-like effects of Avpr1a and Avpr1b receptor antagonists in the dorsal and ventral hippocampus. Neuropeptides 2008, 42:411-421.
66. Landgraf R., Keßler M., Bunk M., Murgatroyd C., Spengler D., Zimbelmann M., et al. Candidate genes of anxiety-related behavior in HAB/LAB rats and mice: focus on vasopressin and glycoxalase-I. Neurosci Biobehav Rev 2007, 31:89-102.
67. Hernando F., Schoots O., Lolait S.J., Burbach J.P.H. Immunohistochemical localization of the vasopressin V1b receptor in the rat brain and pituitary gland: anatomical support for its involvement in the central effects of vasopressin. Endocrinology 2000, 142:1659-1668.
68. Serradeil-Le Gal C., Wagnon J., Tonnerre B., Roux R., Garcia G., Griebel G., et al. An overview of SSR 149415, a selective nonpeptide vasopressin V(1b) receptor antagonist for the treatment of stress-related disorders. CNS Drug Rev 2005, 11:53-68.
69. Syed N., Martens C.A., Hsu W.H. Arginine vasopressin increases glutamate release and intracellular Ca2+ concentration in hippocampal and cortical astrocytes through two distinct receptors. J Neurochem 2007, 103:229-237.
70. Zhao D.K., Ai H.B. Oxytocin and vasopressin involved in restraint water-immersion stress mediated by oxytocin receptor and vasopressin 1b receptor in rat brain. PLOS ONE 2011, 6:e23362.
71. Bradesi S., Martinez V., Lao L., Larsson H., Mayer E.A. Involvement of vasopressin 3 receptors in chronic psychological stress-induced visceral hyperalgesia in rats. Am J Physiol Gastrointest Liver Physiol 2009, 296:G302-G309.
72. Lolait S.J., O'Carroll A.M., Mahan L.C., Felder C.C., Button D.C., Young W.S., et al. Extrapituitary expression of the rat V1b vasopressin receptor gene. Proc Natl Acad Sci USA 1995, 92:6783-6787.
73. Ramanathan G., Cilz N.I., Kurada L., Hu B., Wang X., Lei S. Vasopressin facilitated GABAergic transmission in rat hippocampus via activation of V1A receptors. Neuropharmacology 2012, 63:1218-1226.
74. Egashira N., Mishima K., Iwasaki K., Oishi R., Fujiwara M. New topics in vasopressin receptors and approach to novel drugs: role of the vasopressin receptor in psychological and cognitive functions. J Pharmacol Sci 2009, 109:44-49.
75. Longart M., Liu Y., Karavanova I., Buonanno A. Neuroregulin-2 is developmentally regulated and targeted to dendrites of central neurons. J Com Neurol 2004, 472:156-172.
76. Montero J.C., Rodríguez-Barrueco R., Ocaña A., Díaz-Rodríguez E., Esparís-Ogando A., Pandiella A. Neuregulins and cancer. Clin Cancer Res 2008, 14:3237-3241.
77. Rana O.R., Schauerte P., Kluttig R., Schröder J.W., Koenen R.R., Weber C., et al. Acetylcholine as an age-dependent non-neuronal source in the heart. Auton Neurosci 2010, 156:82-89.
78. Fujii T., Masai M., Misawa H., Okuda T., Takada-Takatori Y., Moriwaki Y., et al. Acetylcholine synthesis and release in NIH3T3 cells coexpressing the high-affinity choline transporter and choline acetyltransferase. J Neurosci Res 2009, 87:3024-3032.
79. Parikh V., St Peters M., Blakely R.D., Sarter M. The presynaptic choline transporter imposes limits on sustained cortical acetylcholine release and attention. J Neurosci 2013, 33:2326-2337.
80. Sarter M., Vinay Parikh V. Choline transporters, cholinergic transmission and cognition. Nat Rev 2005, 6:48-56.
81. Bazalakova M.H., Wright J., Schneble E.J., McDonald M.P., Heilman C.J., Levey A.I., et al. Deficits in acetylcholine homeostasis, receptors and behaviors in choline transporter heterozygous mice. Genes Brain Behav 2007, 6:411-424.
82. Burger S., Döring B., Hardt M., Beuerlein K., Gerstberger R., Geyer J. Co-expression studies of the orphan carrier protein Slc10a4 and the vesicular carriers VAChT and VMAT2 in the rat central and peripheral nervous system. Neuroscience 2011, 193:109-121.
83. Zelano J., Mikulovic S., Patra K., Kühnemund M., Larhammar M., Emilsson L., et al. The synaptic protein encoded by the gene Slc10A4 suppresses epileptiform activity and regulates sensitivity to cholinergic chemoconvulsants. Exp Neurol 2013, 239:73-81.
84. File S.E., Kenny P.J., Cheeta S. The role of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety. Pharmacol Biochem Behav 2000, 66:65-72.
85. Niewiadomska G., Baksalerska-Pazera M., Gernot Riedel G. The septo-hippocampal system, learning and recovery of function. Prog Neuro-Psychoph 2009, 33:791-805.
86. Martin J.R., Driscoll P., Gentsch C. Differential response to cholinergic stimulation in psychogenetically selected rat lines. Psychopharmacology (Berl) 1984, 83:262-267.